Abbott Laboratories (XSWX:ABT) Cash Payments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ABT Abbott Laboratories XSWX:ABT
76 GF Score
Price CHF77.50
GF Value CHF107.55
View Full Analysis

What is Abbott Laboratories Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

XSWX:ABT
76GF Score
Abbott Laboratories XSWX:ABT
Cash Payments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF77.50 is trading 27.9% below its estimated GF Value™ of CHF107.55.

Key valuation signals for XSWX:ABT:

  • Cash Payments:
  • GF Value™: CHF107.55 vs. price of CHF77.50 (27.9% below fair value)
  • GF Score™: 76/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
76GF Score

Get the complete analysis for XSWX:ABT

Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF77.50
Price
CHF107.55
GF Value